文献速递技术与安全

影像学诊断准确性系统评价的报告质量:PRISMA-DTA与PRISMA清单比较

Measuring quality of reporting in systematic reviews of diagnostic test accuracy studies in medical imaging: comparison of PRISMA-DTA and PRISMA.
PubMed 文献 · Ultrasound Obstet Gynecol · 2023-01-12

该研究纳入2020至2021年发表在66本医学影像期刊的173篇诊断准确性系统评价,用PRISMA-DTA、PRISMA-2009和PRISMA-2020评估报告质量。PRISMA-DTA较原版PRISMA识别出更多报告缺陷,尤其在标题、摘要和方法学部分,但仅24.9%的系统评价使用PRISMA-DTA,仅3.0%的期刊推荐使用。

要点

  • PRISMA-DTA在标题、摘要、检索策略、数据提取定义等关键条目上识别出更多报告不足。
  • PRISMA-DTA总体报告评分中位数为72.0%,低于PRISMA-2009的88.9%。
  • PRISMA-DTA在研究者中使用率低(24.9%),期刊推荐率仅3.0%。

诊断标准与关键数值

  • PRISMA-DTA评估中,标题规范报告比例为27.2%,PRISMA-2009和PRISMA-2020均为98.8%。
  • 摘要规范报告比例:PRISMA-DTA为39.3%,PRISMA-2009为97.1%,PRISMA-2020为64.7%。
  • 纳入标准规范报告比例:PRISMA-DTA为67.6%,PRISMA-2009和PRISMA-2020均为94.2%。
  • 检索策略规范报告比例:PRISMA-DTA为28.9%,PRISMA-2009为72.3%,PRISMA-2020为28.9%。
  • 数据提取定义规范报告比例:PRISMA-DTA为14.5%,PRISMA-2009和PRISMA-2020均为91.9%。

临床应用与阅片要点

  • 撰写或审阅诊断准确性系统评价时,应优先使用PRISMA-DTA清单以发现标题、摘要和方法学部分的报告不足。
  • 影像期刊可考虑在投稿指南中推荐PRISMA-DTA,以提高诊断准确性系统评价的报告透明度。

局限性

  • 研究仅纳入2020至2021年发表的系统评价,时间范围有限。
  • 仅评估JCR Q1和Q3期刊,未覆盖所有影像学期刊。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To compare the reporting quality measured by the Preferred Reporting Items for Systematic Reviews and Meta-Analyses of Diagnostic Test Accuracy studies (PRISMA-DTA) vs the original PRISMA checklist for systematic reviews of diagnostic test accuracy studies in imaging and survey the use of PRISMA-DTA by researchers and endorsement by journals.

METHODS: Systematic reviews of DTA studies published in 2020 and 2021 in Quartile 1 and Quartile 3 medical imaging journals (defined by Journal Citation Reports) were identified through PubMed. The reporting of each systematic review was assessed using PRISMA-DTA, PRISMA-2009 and PRISMA-2020. The item scores and overall score were compared among the three checklists. We also examined checklist adoption by the included systematic reviews and surveyed checklist endorsement from author instructions of included journals.

RESULTS: A total of 173 systematic reviews from 66 journals were included. The use of PRISMA-DTA, compared with PRISMA-2009 and PRISMA-2020, identified more issues in the reporting of title (proportion of systematic reviews with proper reporting, 27.2% vs 98.8% vs 98.8%), abstract (39.3% vs 97.1% vs 64.7%), eligibility criteria (67.6% vs 94.2% vs 94.2%), search (28.9% vs 72.3% vs 28.9%), definitions for data extraction (14.5% vs 91.9% vs 91.9%), diagnostic accuracy measures (38.2% vs 93.6% vs 93.6%), synthesis of results (28.9% vs 89.6% vs 73.4%) and results of individual studies (40.5% vs 80.3% vs 80.3%). The overall median reporting score measured by PRISMA-DTA (72.0% (interquartile range (IQR), 66.7-77.8%)) was lower than that measured by PRISMA-2009 (88.9% (IQR, 84.0-92.6%)) and similar to that measured by PRISMA-2020 (74.1% (IQR, 66.7-77.8%)). Additionally, PRISMA-DTA was used by only 43 (24.9%) systematic reviews and endorsed by two (3.0%) journals. These trends remained consistent for reviews published in journals with diverse scientific impact.

CONCLUSIONS: The use of PRISMA-DTA may identify more reporting inadequacies compared with the original PRISMA checklists when assessing diagnostic test accuracy systematic reviews, especially in critical sections such as title, abstract and methods. However, this tool is not commonly used by researchers and is inadequately endorsed by imaging journals. Our findings suggest a strong need to use PRISMA-DTA for reporting of diagnostic test accuracy systematic reviews by authors and its endorsement by journals. © 2022 International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Li, Hou, Li, et al. Measuring quality of reporting in systematic reviews of diagnostic test accuracy studies in medical imaging: comparison of PRISMA-DTA and PRISMA. Ultrasound Obstet Gynecol. 2023. PMID: 36633905. doi:10.1002/uog.26043

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。